Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
30.32
-0.10 (-0.33%)
At close: Nov 18, 2025, 4:00 PM EST
30.36
+0.04 (0.13%)
After-hours: Nov 18, 2025, 7:20 PM EST
Genmab Employees
Genmab had 2,682 employees as of December 31, 2024. The number of employees increased by 478 or 21.69% compared to the previous year.
Employees
2,682
Change (1Y)
478
Growth (1Y)
21.69%
Revenue / Employee
$1,433,881
Profits / Employee
$590,331
Market Cap
18.28B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,682 | 478 | 21.69% |
| Dec 31, 2023 | 2,204 | 544 | 32.77% |
| Dec 31, 2022 | 1,660 | 448 | 36.96% |
| Dec 31, 2021 | 1,212 | 431 | 55.19% |
| Dec 31, 2020 | 781 | 233 | 42.52% |
| Dec 31, 2019 | 548 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GMAB News
- 9 hours ago - Genmab Announces Pricing of Private Offering of Senior Secured Notes and Senior Unsecured Notes and Completion of Syndication of New Senior Secured Term Loan Facility - GlobeNewsWire
- 10 hours ago - Capital Increase in Genmab as a Result of Employee Warrant Exercise - GlobeNewsWire
- 14 hours ago - Genmab Announces EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide Approved by the U.S. Food and Drug Administration for the Treatment of Relapsed or Refractory Follicular Lymphoma - Business Wire
- 8 days ago - Genmab Provides Certain Information Disclosed in Connection with Proposed Private Offering of Senior Secured Notes and Senior Unsecured Notes - GlobeNewsWire
- 8 days ago - Genmab Announces Proposed Private Offering of Senior Secured Notes and Senior Unsecured Notes and Syndication of New Senior Secured Term Loan Facility - GlobeNewsWire
- 10 days ago - Genmab A/S (GMAB) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Genmab to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 15 days ago - Genmab to Showcase Latest Blood Cancer Treatment Advancements at 2025 American Society of Hematology (ASH) Annual Meeting - Business Wire